Feeds

Pfizer sues online pharmacies

US patent infringement allegations

  • alert
  • submit to reddit

Combat fraud and increase customer satisfaction

Pfizer has filed lawsuits against five online pharmacies for selling an unapproved copy of Pfizer's top-selling cholesterol medicine - Lipitor - the company says in a statement.

The suits were filed in US district courts in Delaware and Connecticut against Generic Lipitors, Online Rx DrugStore, WorldMedsRX, B. M. International, and Offshore Pharma.

Pfizer says the sites market a product called Storvas, which is advertised as being manufactured by Ranbaxy Pharmaceuticals Inc of India, a country that doesn't recognise drug patents.

The Pfizer lawsuits claim damages for infringement of Pfizer's patent and trademark rights for Lipitor. The complaints also seek to remove references to Lipitor in advertising materials and to eliminate computer links that misdirect patients to an illegal, unapproved product.

This is the first time a big pharmaceutical firm has tried to halt the sale of illegal generic medicines on the Net. Many dubious online pharmacies, companies which typically fail to provide a contact address or phone number, often sell 'generic variations' of medicines, in particular generic or herbal Viagra. The only FDA-approved brand, however, is Viagra produced by Pfizer, which owns the patent on its active ingredient.

The US Food and Drug Administration (FDA) gets dozens of reports of counterfeit drugs. They may look like the medicines the doctor would prescribe, but they often contain little or no active ingredients, or additional ingredients that could have serious side-effects.

Pfizer filed another suit on 12 April against Look4Generics.com in US District Court in Delaware. The company noted that the Internet provides easy access to websites that sell unapproved or counterfeit pharmaceutical products that could put patient health at risk. ®

Related stories

Big Pharma puts squeeze on Canadian Net pharmacies
E-pharmacies guilty of blatant disregard for health
Drugs agency calls for crackdown in e-pharmacies
Legality of online pharmacies questioned
Unscrupulous Net drugs trade led to death of student
e-Pharmacy sites offer risky prescription
Internet pharmacies draw fire on Capitol Hill

3 Big data security analytics techniques

More from The Register

next story
Dropbox defends fantastically badly timed Condoleezza Rice appointment
'Nothing is going to change with Dr. Rice's appointment,' file sharer promises
Audio fans, prepare yourself for the Second Coming ... of Blu-ray
High Fidelity Pure Audio – is this what your ears have been waiting for?
Did a date calculation bug just cost hard-up Co-op Bank £110m?
And just when Brit banking org needs £400m to stay afloat
MtGox chief Karpelès refuses to come to US for g-men's grilling
Bitcoin baron says he needs another lawyer for FinCEN chat
Zucker punched: Google gobbles Facebook-wooed Titan Aerospace
Up, up and away in my beautiful balloon flying broadband-bot
Apple DOMINATES the Valley, rakes in more profit than Google, HP, Intel, Cisco COMBINED
Cook & Co. also pay more taxes than those four worthies PLUS eBay and Oracle
It may be ILLEGAL to run Heartbleed health checks – IT lawyer
Do the right thing, earn up to 10 years in clink
prev story

Whitepapers

Top three mobile application threats
Learn about three of the top mobile application security threats facing businesses today and recommendations on how to mitigate the risk.
Combat fraud and increase customer satisfaction
Based on their experience using HP ArcSight Enterprise Security Manager for IT security operations, Finansbank moved to HP ArcSight ESM for fraud management.
The benefits of software based PBX
Why you should break free from your proprietary PBX and how to leverage your existing server hardware.
Five 3D headsets to be won!
We were so impressed by the Durovis Dive headset we’ve asked the company to give some away to Reg readers.
SANS - Survey on application security programs
In this whitepaper learn about the state of application security programs and practices of 488 surveyed respondents, and discover how mature and effective these programs are.